What did Ryman Healthcare Limited announce?

Ryman Healthcare Limited (NZX: RYM) filed “Second quarter trading update” with NZX on 11 October 2026, as an operational update announcement.

From the announcement:“Ryman Healthcare reports 379 sales of retirement living occupation right agreements (ORAs) for the quarter ended 30 September 2026 (Q2 FY27), including 312 resales and 67 new sales.”
When was it filed?
11 October 2026
Where is the original?
NZX announcement
Ryman Healthcare Limited logo

Second quarter trading update

Operational Update11 October 2026RYMHealthcare

RYMAN HEALTHCARE LIMITED 1
NZX & ASX RELEASE

Second quarter trading update

12 October 2026

Ryman Healthcare reports 379 sales of retirement living occupation right agreements (ORAs) for the

quarter ended 30 September 2026 (Q2 FY27), including 312 resales and 67 new sales.


Resales volumes reach eight-quarter high

Resales volumes increased 14% on the same period last year, making Q2 FY27 the strongest resale

period in the past eight quarters, underpinned by continued strength in serviced apartments.

Ryman CEO Naomi James said, “Demand for serviced apartments remains strong and continues to

benefit from structural growth of assisted living. We're encouraged by the early response to our Ryman

Select product, which provides residents with greater choice and flexibility of services, with a round

one-third of new serviced apartment applications choosing this option at villages where it has been

rolled out”.

Net resales contract volumes, a lead indicator of future sales, increased 11% on the same period last

year, following the 7% growth year on year seen in Q1 FY27. Growth was driven by strong contracting

activity across both independent and serviced retirement units, with performance broad-based across

most regions including Auckland and Victoria.

Continued sell down of new sales inventory

New retirement living stock reduced by 67 units to 347 units in Q2 FY27, bringing the total reduction

since 31 March 2026 to 132 units

1

. The reduction reflects new sales and the absence of new stock

deliveries , as planned, in the first half of FY27.

The new main building at Richard Hadlee Village in Christchurch opened in October (Q3 FY27), adding

77 retirement living units and 65 care beds, including new care suite and premium care apartment

offerings. With these 142 delivered, Ryman remains on track for its FY27 build guidance of 157–168

retirement living units and aged care beds.

Aged care demand remains strong

Total aged care occupancy was 94.0% in Q2 FY27, up 3.3 percentage points on the same period last

year. Growth was driven by the filling of recently developed care centres, including Kevin Hickman

Village in Christchurch which is now full after opening 15 months ago.

Occupancy in mature aged care centres was 95.4% in Q2 FY27, down slightly from 95.7% in the same

period last year, reflecting a more acute period of winter illness in some New Zealand villages.


1

Stock reduction 127 new sales and 5 retirement living units reclassified to aged care.

RYMAN HEALTHCARE LIMITED 2
Occupancy across Ryman’s five mature aged care centres in Victoria reached 97.9% in Q2 FY27, up from

96.1% in the same period last year.

James said, “Demand for aged care continues to grow in both New Zealand and Australia, supported by

demographic trends and the quality of our offering. Seamless access to aged care remains one of the

key reasons residents choose Ryman, and our recently launched Resident Fund product provides

another option to support residents as their care needs change.”

From 1 September, Ryman has expanded its Resident Fund product in New Zealand, enabling residents

to use their capital from their prior retirement living unit to fund both care accommodation charges

and base care fees when needed.

Market conditions

Naomi James said, “We are making progress towards our target of matching resales with turnover by

the end of FY27 and we've entered the second half with a healthy contract book. While housing market

conditions continue to be soft, demand for retirement living, assisted living and aged care remains

resilient across New Zealand and Australia, reflecting structural demographic drivers that are less

dependent on housing market conditions. We are focused on executing the initiatives within our

control, including targeted sales strategies and expanding pricing and product options to improve

affordability and accessibility for prospective residents , consistent with our strategy to grow our high-

quality recurring earnings which are less reliant on house price growth.”


Sales of occupation right agreements for retirement village units


Sales volume (#) FY26 FY27



Q1 Q2 Q3 Q4 FY Q1 Q2

New sales

Independent 56 75 61 49 241 35 38


Serviced 17 18 40 32 107 25 29


Total 73

93 101 81 348 60 67

Resales

Independent 133 119 133 129 514 113 133


Serviced 131 155 141 121 548 152 179


Total 264 274 274 250 1,062 265 312

Total

Independent 189

194 194 178 755 148 171


Serviced 148 173 181 153 655 177 208


Total 337

367 375 331 1,410 325 379

Note: Includes ORA sales on retirement village units only and excludes ORAs and RADs on aged care accommodation. Sales are recognised when a resident

takes occupation of a retirement village unit, which typically aligns with settlement. FY26 sales include 39 ORAs from residents who have elected to

relocate to other Ryman villages from Margaret Stoddart and Woodcote following the closure of these villages (Q2: 5 sales, Q3: 32 sales, Q4: 2 sales).

ENDS

Authorised by

Morgan Powell, General Counsel



RYMAN HEALTHCARE LIMITED 3
About Ryman

Founded in Christchurch in 1984, Ryman Healthcare is New Zealand’s largest retirement living and aged care

provider, and the leading integrated retirement living and aged care operator in Victoria. Dual listed on the NZX

and ASX, Ryman owns and operates 47 integrated retirement villages across New Zealand and Australia,

providing homes to over 15,500 residents and employing 7,800 dedicated team members.

Ryman’s villages provide a fully integrated continuum of care, bringing together independent living, assisted

living, and aged care services within a single community. This model offers residents choice, continuity, and a

genuine home for life experience as their needs change, while giving families confidence and peace of mind.

Committed to high standards of quality and service, Ryman delivers exceptional living and care experiences

alongside long-term value for residents, families, and shareholders.

Contacts

For investor relations information

Hayden Strickett, Head of Investor Relations

hayden.strickett@rymanhealthcare.com


For media information

Sarah Greig, General Manager Corporate Affairs

and Communications

sarah.greig@rymanhealthcare.com

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • SUM — Summerset Group Holdings Limited: 3Q26 Metrics - Sales of Occupation Rights
    2026-10-11

    “Sales outlook for remainder of 2026 Looking ahead, Mr Scoullar said Summerset continued to see good demand and was entering Q4 with a solid pipeline of potential contracts, although settlement timing remained influenced by prospective residents’ ability to sell their existing…”

  • PHL — Promisia Healthcare Limited: Operational Update - Q2 FY27
    2026-10-13

    “Market Announcement 14 October 2026 Q2 FY27 OPERATIONAL UPDATE For the quarter ended 30 September 2026 Promisia Healthcare Limited (Promisia) (NZX: PHL) provides the following operational update for the second quarter of FY27. Occupancy Update – September 2026 The table be…”

  • PHL — Promisia Healthcare Limited: ASM 2026 Presentation
    2026-08-27

    “- 4 - FY27 outlook Against that backdrop, we remain very confident in the outlook for FY27. We have reaffirmed our guidance for underlying EBITDAF of at least $8 million, representing growth of at least 20% on FY26. That guidance is based on our exist…”